Overview: Interleukin-6 TestIntroduction: The Interleukin-6 Test detects IL-6 to assess inflammation or infection, causing fever or joint pain. Aligned with 2023 ACR guidelines, it uses immunoassay for high specificity, supporting immune screening. This test is critical for guiding diagnosis, treatment planning, and improving outcomes in immunology for patients with suspected inflammatory or infectious conditions.
Other Names: IL-6 Assay, Inflammation Marker Test.
FDA Status: Laboratory-developed test (LDT), meeting immunology standards for diagnostic accuracy.
Historical Milestone: IL-6 testing began in the 1980s with inflammation research. Immunoassay-based methods improved in the 2000s, enhancing diagnostic precision.
Purpose: Detects IL-6 to diagnose inflammation or infections, guides treatment, and evaluates patients with fever or joint pain.
Test Parameters: 1. Interleukin-6
Pretest Condition: No fasting required. Collect serum, plasma, or CSF. Report history of fever, joint pain, or infection symptoms.
Specimen: Serum (SST, 2-5 mL), Plasma (EDTA, 2-4 mL), CSF (sterile container, 1-2 mL). Transport in a biohazard container.
Sample Stability at Room Temperature: 8 hours
Sample Stability at Refrigeration: 7 days
Sample Stability at Frozen: 6 months
Medical History: Document fever, joint pain, fatigue, or history of infections or inflammatory diseases. Include current medications, especially anti-inflammatory drugs.
Consent: Written consent required, detailing the tests purpose, inflammation or infection implications, and risks of blood or CSF collection.
Procedural Considerations: Uses immunoassay to measure IL-6 in serum, plasma, or CSF. Results are available in 1-2 days, supporting rapid clinical decisions. Performed in laboratories, often for inflammation or infection diagnosis.
Factors Affecting Result Accuracy: Hemolysis, lipemia, or improper sample storage can affect results. Insufficient sample volume may reduce accuracy.
Clinical Significance: Elevated IL-6 suggests inflammation (e.g., rheumatoid arthritis) or infection, guiding anti-inflammatory or antibiotic therapy. Normal levels may require further testing.
Specialist Consultation: Consult a rheumatologist or infectious disease specialist for result interpretation and treatment planning.
Additional Supporting Tests: CRP, ESR, or blood cultures to confirm inflammation or infection diagnosis.
Test Limitations: Not specific to one condition; various inflammatory states elevate IL-6. Clinical correlation is needed.
References: ACR Inflammation Guidelines, 2023; Arthritis & Rheumatology, Kishimoto T, 2022.
